Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allopurinol for chronic prostatitis.

M McNaughton Collins1, T Wilt

  • 1General Internal Medicine (111-0), Minneapolis VA/VISN 13 Center for Chronic Diseases Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA. MACDONALD.RODERICK@minneapolis.va.gov

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials.

Cancer treatment reviews·2009
Same author

A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma.

Cancer treatment reviews·2008
Same author

Targeted therapy for advanced renal cell carcinoma.

The Cochrane database of systematic reviews·2008
Same author

Bisphosphonates for advanced prostate cancer.

The Cochrane database of systematic reviews·2006
Same author

Epidemiology of chronic prostatitis.

Current opinion in urology·2006
Same author

Screening for prostate cancer.

The Cochrane database of systematic reviews·2006
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

This study investigated allopurinol for chronic prostatitis. Results showed allopurinol improved patient-reported discomfort and pain, but more research is needed to confirm effectiveness.

Area of Science:

  • Urology
  • Pharmacology
  • Clinical Trials

Background:

  • Chronic prostatitis is a persistent inflammatory condition affecting many men.
  • Current treatment options for chronic prostatitis can be limited in efficacy.
  • Allopurinol, a xanthine oxidase inhibitor, has not been extensively studied for prostatitis.

Purpose of the Study:

  • To evaluate the efficacy of allopurinol in managing symptoms of chronic prostatitis.
  • To assess the impact of allopurinol on patient-reported discomfort and pain.
  • To examine biochemical changes associated with allopurinol treatment in chronic prostatitis.

Main Methods:

  • A systematic search of multiple databases identified randomized controlled trials.
  • Inclusion criteria focused on randomized trials comparing allopurinol to placebo for chronic prostatitis.

Related Experiment Videos

  • Data extraction included patient-reported discomfort, pain scores, and biochemical markers.

    • Main Results:

    • One trial involving 54 men met the inclusion criteria.
    • Allopurinol significantly reduced patient-reported discomfort and investigator-graded prostate pain compared to placebo.
    • Allopurinol treatment led to lower levels of urate and xanthine in serum, urine, and prostatic secretions, with no significant side effects reported.

    Conclusions:

    • A single trial suggests allopurinol may improve symptoms and biochemical parameters in chronic prostatitis.
    • The current evidence is limited due to the small sample size and methodological concerns.
    • Further rigorous studies with standardized outcomes are required to confirm allopurinol's efficacy for chronic prostatitis.